Back

Human Engineered Heart Tissue Models for Pharmacological Studies- Inhibition of Small-Conductance Ca2+-activated K+ (KCa2) channel

Nadel, A.; Kaluzna, E.; Zimna, A.; Kowala, A.; Barszcz, A.; Mackiewicz, U.; Rozwadowska, N.; Kolanowski, T. J.

2025-10-02 developmental biology
10.1101/2025.09.30.679523 bioRxiv
Show abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia increasing stroke risk. Current treatments show limited effectiveness and can cause serious side effects. At the moment there is a lack of well-established human models recapitulating complex cardiac microenvironment for studying potential AF therapies. To address the limitations of existing models we developed 3D in vitro human Engineered Heart Tissue (EHT) model using atrial and ventricular human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with either human atrial fibroblasts (HAF) or human ventricular fibroblasts (HVF).These chamber-specific EHTs exhibit differences in gene expression, ion channels and physiological responses, enabling studying Frank-Starling mechanisms and Ca2+ response. Using KCa2 channel inhibitor AP14145, we observed increased contraction force and prolonged relaxation time, suggesting negative modulation of KCa2.2/KCa2.3 channels and increased atrial-effective refractory period (AERP). The EHT model provides a valuable platform for examining KCa2 channel inhibitors impact and evaluating chamber-specific drug effects in controlled in vitro settings.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.